Combination Therapy of Microwave Ablation and Cellular Immunotherapy for Hepatocellular Carcinoma

NCT02851784 · clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
40
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Chinese PLA General Hospital